Sidelining safety--the FDA's inadequate response to the IOM. [electronic resource]
Producer: 20070910Description: 960-3 p. digitalISSN:- 1533-4406
- Drug Approval -- legislation & jurisprudence
- Drug-Related Side Effects and Adverse Reactions
- Government Regulation
- Models, Organizational
- National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
- Organizational Innovation
- Product Surveillance, Postmarketing
- United States
- United States Food and Drug Administration -- organization & administration
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.